TORONTO, ON / ACCESS Newswire / January 8, 2026 / Inventus Mining Corp. (TSXV:IVS) ("Inventus" or the "Company")is ...

Take an in-depth look at the treatment of revenues and expenses within the accrual method of accounting and learn why many ...

Big wins like that helped fuel Berkshire's market-beating growth. The conglomerate has delivered an average annual return of ...

Fidelity's FQAL is a lesser-known quality-themed fund with a 0.15% expense ratio and $1.2B in assets under management. This ...

Rolls-Royce shares rise as signals from Trump's defence calls boost European stocks, prompting investors to re-evaluate risk ...

RenX Enterprises Corp. (NASDAQ: RENX) (the 'Company”) today provided an update on a year that management views as ...

Discover the top 3 undervalued Hotels, Restaurants & Leisure stocks for Friday, January 09 based on AAII’s Stock Grades.

Q1 2026 Earnings Call Transcript January 8, 2026 Acuity Brands, Inc. beats earnings expectations. Reported EPS is $4.69, ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

Q2 2026 Earnings Call Transcript January 8, 2026 RPM International Inc. misses on earnings expectations. Reported EPS is $1.2 ...

COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones.

LCNB Corp. is rated a Buy supported by high asset quality and attractive valuation metrics. Learn more about LCNB stock here.